Welltower Inc
Q2 2026 Earnings
Market Reaction
S&P 500 over the same 30 days: +4.08%.
Did WELL Beat Earnings? Q2 2026 Results
Welltower delivered a standout second quarter for 2026, posting normalized FFO of $1.60 per diluted share against a consensus estimate of $0.65, a beat of 146.15% that reflected the sweeping scale of the company's recent expansion. Revenue reached $3.54 billion, up 40.9% year-over-year and ahead of the $3.39 billion analysts had expected, with the Seniors Housing Operating segment serving as the primary engine, generating $3.00 billion in consolidated SHO revenues alone. The April 1 closing of the Amica Senior Lifestyles acquisition, encompassing 38 Canadian senior housing communities at a pro rata purchase price of C$4.10 billion, was the single largest contributor to that revenue surge, compounding organic momentum that included 20.5% SHO same-store NOI growth and average occupancy climbing to 89.4% from 86.1% a year ago. With institutional ownership near 95% and analyst sentiment broadly constructive, investor confidence appears well-anchored. Management raised full-year 2026 normalized FFO guidance to $6.36-$6.44 per diluted share and lifted the quarterly dividend 15% to $0.85 per share.
- SHO same store NOI growth of 20.5% year-over-year
- 330 basis points of average occupancy growth in SHO portfolio
- 5.2% growth in Revenue Per Occupied Room (RevPOR)
- SHO same store occupancy reached 89.4%, up from 86.1% a year ago
- Total portfolio SSNOI growth of 15.5%
- 93.0% private pay revenue mix in Seniors Housing Operating
- Seniors Housing Triple-net SSNOI growth of 5.2%
- Long-Term/Post-Acute Care SSNOI growth of 2.9%
- Outpatient Medical SSNOI growth of 2.4%
- U.S. SHO SS RevPOR YoY growth of 5.3%, U.K. 3.9%, Canada 6.1%
Forward Guidance & Outlook
Welltower raised its full-year 2026 normalized FFO guidance to $6.36–$6.44 per diluted share from the prior range of $6.21–$6.35. GAAP net income guidance was revised to $3.11–$3.19 per diluted share from $3.24–$3.38. Blended SSNOI growth is expected at 13.75%–16.00%, with SHO approximately 18.5%–21.5%, Seniors Housing Triple-net approximately 3.5%–4.5%, Outpatient Medical approximately 2.0%–3.0%, and Long-Term/Post-Acute Care approximately 2.0%–3.0%. G&A expenses are anticipated at approximately $265–$270 million with stock-based compensation of approximately $60 million. Pro rata disposition proceeds of $1.1 billion are expected at a blended yield of 6.8% over the next twelve months. Guidance includes only announced or closed acquisitions and no additional capital transactions.
WELL YoY Financials
WELL Revenue by Segment
WELL Revenue by Geography
Figures from SEC filings and company reports. Not investment advice.